Sildenafil Citrate

Sildenafil Citrate
  • Nomen:Sildenafil Citrate
  • Catalogue No.CPDD2041
  • CAS No.:171599-83-0
  • Pondus hypotheticum:666.703
  • Formulae chemica:C28H38N6O11S
  • Investigationes scientificae tantum, non aegros.

    Product Detail

    Product Tags

    Pack Size Availability Pretium (USD)

    Nomen chemicum:

    5-(2-ethoxy-5-((4-methylpiperazin-1-yl) sulfonyl) phenyl) -1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin- 7-unum 2-hydroxypropane-1,2,3-tricarboxylatum

    SMILES Code:

    "CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)CC(C(=O)O )C(C(O)O)(C(=O)O)O "

    InChi Code:

    InChI=1S/C22H30N6O4S.C6H8O7/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9- 18(16)32-6-2)33(30,31)28-12-10- 26(3)11-13-28; 7-3(8) 1-6(13,5(11)12)2-4(9)10/h8-9,14H,5-7,10-13H2; 1-4H3(H,23,24,29);

    InChi Key:

    DEIYFTQMQPDXOT-UHFFFAOYSA-N

    Keyword:

    Sildenafil Citrate;UK 92480-10;UK-92,480-10; Revatio; VIAGRA171599-83-0;CAS:171599-83-0;CAS:171599-83-0

    Solubilitas:Solutum in DMSO

    Repono:0 - 4° C pro brevi termino (dies ad hebdomades), vel -20° C ad terminum longum (menses)

    Descriptio:

    Sildenafil, Citrate est forma citrata Sildenafil. Sildenafil est inhibitor selectivus PDE5 (type 5 cGMP phosphodiesterasis) quae catalysin hydrolyseos 3',5'-cyclicae monophosphatis guanosini (cGMP). Sicut inhibitor PDE5, Sildenafil relatum est ad augendae neuro-, synapto- et angiogenesis in rat exemplaribus ictuum et praeterea vasodilator lenis esse traditur. Sildenafil etiam ostensum est ad indomethacin-actionem parvam ulcerationem intestinorum per NO/cGMP- mechanismum dependens.

    Target: PDE5




  • Previous:
  • Next:

  • Related Products

    Whatsapp Online Chat!